Sarah Gephine
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarah Gephine has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Jean-Marie Grosbois
FormAction Santé, Pérenchies, France
13 shared publicationsOlivier Le Rouzic
Univ. Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, U1019 - UMR 9017- CIIL, Centre de Référence Constitutif des Maladies Pulmonaires Rares, Lille, France
10 shared publicationsCécile Chenivesse
Univ. Lille
7 shared publicationsDidier Saey
Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (CR-IUCPQ), Université Laval, Québec, Canada
6 shared publicationsFrançois Maltais
Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (CR-IUCPQ), Université Laval, Québec, Canada
5 shared publications- François Maltais
Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, Canada
5 shared publications
Latest Publications
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA5098
One-year survival after home-based pulmonary rehabilitation: a cohort study of 3,754 individuals with chronic respiratory diseases.
Aim. Although the effectiveness of home-based pulmonary rehabilitation (PR) has been reported in several chronic respiratory diseases, data on post-PR survival and associated factors remain limited, especially beyond COPD. The study aimed to assess one-year survival and its association with post-PR changes in clinical outcomes. Methods. This retrospective pre-post study used prospectively collected data from January 2010 to May 2025. Participants performed an 8-week home-based PR programme with face-to-face supervised sessions. Quality of life (CAT), dyspnea (mMRC), exercise tolerance (6-min stepper test, 6MST), and anxiety/depression (HADS) were assessed before and after PR. One-year survival was analysed using Kaplan Meir curves and Cox regression models. Results. Overall, 3,754 participants were included: 1,881 (50%) COPD, 768 (20%) ILD, and 379 (10%) asthma. One-year survival was 88% overall and 89%, 74% and 97% in COPD, ILD and asthma, respectively. Non-survivors were older, more often male and smokers, more frequently oxygen-dependent, and had lower body mass index, greater airflow obstruction, worse dyspnoea and quality of life, higher physical frailty, and reduced exercise capacity than survivors (all p<0.01). Post-PR changes in outcomes were independently associated with one-year survival (CAT HR 1.4, 95% CI 1.1–1.7; mMRC HR 2.0, 95% CI 1.6–2.4; HADS-D HR 1.4, 95% CI 1.2–1.6; 6MST HR 0.6, 95% CI 0.5–0.8; all p<0.005). Conclusion. In a large real-world cohort, one-year mortality after PR was 12% overall, highest in ILD (26%), as expected given disease progression. Changes in quality of life, dyspnea, depressive symptoms and exercise capacity after PR were independently associated with survival highlighting their potential prognostic value beyond the underlying disease.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA5098
One-year survival after home-based pulmonary rehabilitation: a cohort study of 3,754 individuals with chronic respiratory diseases.
Aim. Although the effectiveness of home-based pulmonary rehabilitation (PR) has been reported in several chronic respiratory diseases, data on post-PR survival and associated factors remain limited, especially beyond COPD. The study aimed to assess one-year survival and its association with post-PR changes in clinical outcomes. Methods. This retrospective pre-post study used prospectively collected data from January 2010 to May 2025. Participants performed an 8-week home-based PR programme with face-to-face supervised sessions. Quality of life (CAT), dyspnea (mMRC), exercise tolerance (6-min stepper test, 6MST), and anxiety/depression (HADS) were assessed before and after PR. One-year survival was analysed using Kaplan Meir curves and Cox regression models. Results. Overall, 3,754 participants were included: 1,881 (50%) COPD, 768 (20%) ILD, and 379 (10%) asthma. One-year survival was 88% overall and 89%, 74% and 97% in COPD, ILD and asthma, respectively. Non-survivors were older, more often male and smokers, more frequently oxygen-dependent, and had lower body mass index, greater airflow obstruction, worse dyspnoea and quality of life, higher physical frailty, and reduced exercise capacity than survivors (all p<0.01). Post-PR changes in outcomes were independently associated with one-year survival (CAT HR 1.4, 95% CI 1.1–1.7; mMRC HR 2.0, 95% CI 1.6–2.4; HADS-D HR 1.4, 95% CI 1.2–1.6; 6MST HR 0.6, 95% CI 0.5–0.8; all p<0.005). Conclusion. In a large real-world cohort, one-year mortality after PR was 12% overall, highest in ILD (26%), as expected given disease progression. Changes in quality of life, dyspnea, depressive symptoms and exercise capacity after PR were independently associated with survival highlighting their potential prognostic value beyond the underlying disease.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA2023
Feasibility of performing the 6-minute stepper test with remote supervision in adults with chronic respiratory disease: a multicentre validation study.
Aim: The six-minute stepper test (6MST) is a valid tool to assess exercise capacity in people with chronic respiratory diseases; however, its feasibility under remote supervision remains unknown despite its relevance for telerehabilitation. This study compared the intermodal reliability and safety of home-based 6MST performed under remote versus in-person supervision. Methods: This prospective multicentre study included participants with chronic obstructive pulmonary disease (COPD; GOLD 2–4) or interstitial lung disease (ILD). Three 6MSTs were performed at home during separate visits done 3–5 days apart. The first 6MST was performed with in-person supervision and served as reference and familiarisation. The two subsequent tests were conducted under in-person supervision or remote supervision via videoconferencing, in a randomised order. Step count, pulse oxygen saturation (SpO₂), and heart rate were recorded. Agreement and bias were assessed using intraclass correlation coefficients (ICC) and Bland–Altman analyses. Results: Fifty-two participants completed the protocol (73% COPD, mean FEV₁ 49±17%; 27% ILD, mean FVC 83±17% and DLCO 53±13%). The mean difference in step count between the two randomised 6MSTs was −1 step (95%CI −13 to 12), with limits of agreement from −85 to 86 steps. Agreement was excellent (ICC=0.977, 95%CI 0.960–0.987). Nadir SpO₂ and end-exercise heart rate were similar between conditions. No major adverse events occurred. Minor technical issues were reported in nine participants (17%) during remote testing. Conclusion: The 6MST supervised remotely was feasible, safe and highly comparable to in-person supervision in adults with stable chronic respiratory diseases, although individual differences may exceed the minimal clinically important difference of 40 steps.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA2023
Feasibility of performing the 6-minute stepper test with remote supervision in adults with chronic respiratory disease: a multicentre validation study.
Aim: The six-minute stepper test (6MST) is a valid tool to assess exercise capacity in people with chronic respiratory diseases; however, its feasibility under remote supervision remains unknown despite its relevance for telerehabilitation. This study compared the intermodal reliability and safety of home-based 6MST performed under remote versus in-person supervision. Methods: This prospective multicentre study included participants with chronic obstructive pulmonary disease (COPD; GOLD 2–4) or interstitial lung disease (ILD). Three 6MSTs were performed at home during separate visits done 3–5 days apart. The first 6MST was performed with in-person supervision and served as reference and familiarisation. The two subsequent tests were conducted under in-person supervision or remote supervision via videoconferencing, in a randomised order. Step count, pulse oxygen saturation (SpO₂), and heart rate were recorded. Agreement and bias were assessed using intraclass correlation coefficients (ICC) and Bland–Altman analyses. Results: Fifty-two participants completed the protocol (73% COPD, mean FEV₁ 49±17%; 27% ILD, mean FVC 83±17% and DLCO 53±13%). The mean difference in step count between the two randomised 6MSTs was −1 step (95%CI −13 to 12), with limits of agreement from −85 to 86 steps. Agreement was excellent (ICC=0.977, 95%CI 0.960–0.987). Nadir SpO₂ and end-exercise heart rate were similar between conditions. No major adverse events occurred. Minor technical issues were reported in nine participants (17%) during remote testing. Conclusion: The 6MST supervised remotely was feasible, safe and highly comparable to in-person supervision in adults with stable chronic respiratory diseases, although individual differences may exceed the minimal clinically important difference of 40 steps.
- 6 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Tolérance à l’effort, capacité fonctionnelle et syndrome de fragilité : place des tests de terrain dans la maladie pulmonaire obstructive chronique (MPOC)
Le tableau clinique des patients atteints de maladie pulmonaire obstructive chronique (MPOC) est caractérisé par une dysfonction des muscles locomoteurs, une intolérance à l’effort, ainsi qu’une dépendance fonctionnelle pouvant conduire à un syndrome de fragilité. L’utilisation des tests de terrain, tels que le test de lever de chaise d’une minute (1STS), s’est généralisée dans les milieux cliniques pour évaluer la tolérance à l’effort des patients, à défaut parfois d’une évaluation préalable, indispensable à leur validation et utilisation sécuritaire. De plus, nouvellement empruntés à la gériatrie clinique, la capacité fonctionnelle et le syndrome de fragilité ne sont encore que trop peu documentés dans la MPOC, et leur évaluation est rare dans un contexte de réadaptation respiratoire. Elle est pourtant nécessaire chez les patients présentant une intolérance à l’effort sévère, tels que les patients atteints d’insuffisance respiratoire chronique, pour qui les objectifs et les programmes de réadaptation respiratoire nécessiteraient davantage de personnalisation.Le premier objectif de cette thèse était d’évaluer les mécanismes musculaires, cardiorespiratoires et symptomatiques limitants la réalisation du 1STS chez des patients atteints de MPOC. Le second objectif était d’évaluer l’efficacité d’un programme de réadaptation respiratoire à domicile chez des patients atteints de MPOC et d’insuffisance respiratoire chronique, ainsi que l’impact du syndrome de fragilité physique sur l’efficacité et l’adhésion au programme de réadaptation.Les premiers travaux de cette thèse ont démontré que bien qu'il s'agisse d'un test de terrain, le 1STS entraîne une réponse cardiorespiratoire quasi maximale chez les patients atteints de MPOC sévère. Par ailleurs, la mise en évidence d’un retard dans la récupération des paramètres cardiorespiratoires à la suite du 1STS, chez les patients atteints de MPOC, démontre la pertinence clinique de surveiller sa période de récupération. Bien que la principale limitation du 1STS semblait être cardiorespiratoire, la fatigue musculaire du quadriceps, présente chez plus de deux tiers des patients à la suite du 1STS, a pu également contribuer à la limitation de la performance au 1STS.Les travaux associés au deuxième objectif de cette thèse ont mis en évidence que le syndrome de fragilité physique affectait près de la moitié des patients atteints de MPOC et d'insuffisance respiratoire chronique, débutant une réadaptation respiratoire. Ces patients fragiles étaient caractérisés par une diminution de l’activité physique, de la tolérance à l’effort et de la capacité fonctionnelle par rapport à leurs homologues non-fragiles. Toutefois, la fragilité physique n’était pas un obstacle pour bénéficier de l’intervention à court et moyen termes. Par ailleurs, le programme de réadaptation respiratoire permettait l’amélioration du syndrome de fragilité chez plus de 80% des patients initialement fragiles.En conclusion, les travaux de cette thèse ont mis en évidence : i) L’utilité clinique des tests de terrain, tels que le 1STS, pour évaluer la tolérance à l’effort des patients atteints de MPOC ; et ii) L’importance d’évaluer la fragilité physique chez les patients atteints de MPOC et d'insuffisance respiratoire chronique afin de personnaliser l'approche de la réadaptation respiratoire et d'aider les patients à retrouver un état plus robuste après l'intervention.
- 6 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Tolérance à l’effort, capacité fonctionnelle et syndrome de fragilité : place des tests de terrain dans la maladie pulmonaire obstructive chronique (MPOC)
Le tableau clinique des patients atteints de maladie pulmonaire obstructive chronique (MPOC) est caractérisé par une dysfonction des muscles locomoteurs, une intolérance à l’effort, ainsi qu’une dépendance fonctionnelle pouvant conduire à un syndrome de fragilité. L’utilisation des tests de terrain, tels que le test de lever de chaise d’une minute (1STS), s’est généralisée dans les milieux cliniques pour évaluer la tolérance à l’effort des patients, à défaut parfois d’une évaluation préalable, indispensable à leur validation et utilisation sécuritaire. De plus, nouvellement empruntés à la gériatrie clinique, la capacité fonctionnelle et le syndrome de fragilité ne sont encore que trop peu documentés dans la MPOC, et leur évaluation est rare dans un contexte de réadaptation respiratoire. Elle est pourtant nécessaire chez les patients présentant une intolérance à l’effort sévère, tels que les patients atteints d’insuffisance respiratoire chronique, pour qui les objectifs et les programmes de réadaptation respiratoire nécessiteraient davantage de personnalisation.Le premier objectif de cette thèse était d’évaluer les mécanismes musculaires, cardiorespiratoires et symptomatiques limitants la réalisation du 1STS chez des patients atteints de MPOC. Le second objectif était d’évaluer l’efficacité d’un programme de réadaptation respiratoire à domicile chez des patients atteints de MPOC et d’insuffisance respiratoire chronique, ainsi que l’impact du syndrome de fragilité physique sur l’efficacité et l’adhésion au programme de réadaptation.Les premiers travaux de cette thèse ont démontré que bien qu'il s'agisse d'un test de terrain, le 1STS entraîne une réponse cardiorespiratoire quasi maximale chez les patients atteints de MPOC sévère. Par ailleurs, la mise en évidence d’un retard dans la récupération des paramètres cardiorespiratoires à la suite du 1STS, chez les patients atteints de MPOC, démontre la pertinence clinique de surveiller sa période de récupération. Bien que la principale limitation du 1STS semblait être cardiorespiratoire, la fatigue musculaire du quadriceps, présente chez plus de deux tiers des patients à la suite du 1STS, a pu également contribuer à la limitation de la performance au 1STS.Les travaux associés au deuxième objectif de cette thèse ont mis en évidence que le syndrome de fragilité physique affectait près de la moitié des patients atteints de MPOC et d'insuffisance respiratoire chronique, débutant une réadaptation respiratoire. Ces patients fragiles étaient caractérisés par une diminution de l’activité physique, de la tolérance à l’effort et de la capacité fonctionnelle par rapport à leurs homologues non-fragiles. Toutefois, la fragilité physique n’était pas un obstacle pour bénéficier de l’intervention à court et moyen termes. Par ailleurs, le programme de réadaptation respiratoire permettait l’amélioration du syndrome de fragilité chez plus de 80% des patients initialement fragiles.En conclusion, les travaux de cette thèse ont mis en évidence : i) L’utilité clinique des tests de terrain, tels que le 1STS, pour évaluer la tolérance à l’effort des patients atteints de MPOC ; et ii) L’importance d’évaluer la fragilité physique chez les patients atteints de MPOC et d'insuffisance respiratoire chronique afin de personnaliser l'approche de la réadaptation respiratoire et d'aider les patients à retrouver un état plus robuste après l'intervention.
- 14 March 2026
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 43 (1) , 105-109
Enquête française sur le rôle des proches aidants dans les maladies respiratoires chroniques
- 14 March 2026
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 43 (1) , 105-109
Enquête française sur le rôle des proches aidants dans les maladies respiratoires chroniques
- Open Access
- 4 March 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e003599
PRHOCARER study: protocol for a multicentre, convergent, mixed-methods trial assessing the effectiveness of pulmonary rehabilitation programmes and the needs of informal carers of people with chronic respiratory diseases
Introduction: As the population ages, informal carers play an increasingly essential role in supporting patients with chronic respiratory diseases (CRDs), often at the expense of their own health. While the psychological effects are well documented, less is currently known about the physical toll of caregiving. Some trials have shown promising outcomes from pulmonary rehabilitation (PR) interventions targeting both patients and informal carers, but study designs have been limited. This trial aims to better understand informal carers’ experience by assessing their physical, psychological and social well-being at home, before and after the individual they care for participates in either a home-based or centre-based PR programme. Methods and analyses: This is a multicentre, convergent parallel mixed-methods study using a before-and-after intervention design. 54 informal carers of patients with CRDs will be recruited from two PR services—27 from a home- and 27 from a centre-based programme. Assessments of the physical, psychological and social well-being of the informal carers will be conducted at home. Semistructured interviews, conducted within 2-weeks post-PR, will explore informal carers’ expectations, experiences and support needs. The home-based PR programme will involve weekly 90-min sessions for 8 weeks, supervised at home by a care manager. Informal carers will have the opportunity to participate in PR sessions in accordance with their needs, availability and patient preferences. At the centre-based PR site, patients with CRDs will be enrolled in a 4-week inpatient PR programme or in a 5- to 10-week outpatient PR programme, consisting of 2 or 4 supervised sessions per week (for a total of 20 supervised sessions). Informal carers’ attendance will be tracked at both sites. Ethics and dissemination: Ethical approval was obtained from the University Sud Mediterranean 3 (24.04596.000457;2024/10/07). The trial results will be presented at scientific conferences, submitted to peer-reviewed journals and shared with decision-makers. Trial registration number: NCT06832709 .
- 4 March 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e003599
Open AccessPRHOCARER study: protocol for a multicentre, convergent, mixed-methods trial assessing the effectiveness of pulmonary rehabilitation programmes and the needs of informal carers of people with chronic respiratory diseases
Introduction: As the population ages, informal carers play an increasingly essential role in supporting patients with chronic respiratory diseases (CRDs), often at the expense of their own health. While the psychological effects are well documented, less is currently known about the physical toll of caregiving. Some trials have shown promising outcomes from pulmonary rehabilitation (PR) interventions targeting both patients and informal carers, but study designs have been limited. This trial aims to better understand informal carers’ experience by assessing their physical, psychological and social well-being at home, before and after the individual they care for participates in either a home-based or centre-based PR programme. Methods and analyses: This is a multicentre, convergent parallel mixed-methods study using a before-and-after intervention design. 54 informal carers of patients with CRDs will be recruited from two PR services—27 from a home- and 27 from a centre-based programme. Assessments of the physical, psychological and social well-being of the informal carers will be conducted at home. Semistructured interviews, conducted within 2-weeks post-PR, will explore informal carers’ expectations, experiences and support needs. The home-based PR programme will involve weekly 90-min sessions for 8 weeks, supervised at home by a care manager. Informal carers will have the opportunity to participate in PR sessions in accordance with their needs, availability and patient preferences. At the centre-based PR site, patients with CRDs will be enrolled in a 4-week inpatient PR programme or in a 5- to 10-week outpatient PR programme, consisting of 2 or 4 supervised sessions per week (for a total of 20 supervised sessions). Informal carers’ attendance will be tracked at both sites. Ethics and dissemination: Ethical approval was obtained from the University Sud Mediterranean 3 (24.04596.000457;2024/10/07). The trial results will be presented at scientific conferences, submitted to peer-reviewed journals and shared with decision-makers. Trial registration number: NCT06832709 .
- Open Access
- 4 February 2026
- Published by Wiley in Journal of Clinical Nursing
- Vol. 35 (6) , 2658-2671
Is a Hybrid Pulmonary Rehabilitation Programme Feasible and Effective in Individuals With COPD After an Exacerbation‐Related Hospitalisation: A Mixed Methods Study
Aim: To combine qualitative and quantitative data to evaluate the feasibility, participant satisfaction and effectiveness of a hybrid pulmonary rehabilitation programme following hospital discharge for an exacerbation of chronic obstructive pulmonary disease (COPD). Design: Convergent parallel mixed method study nested in a larger ongoing prospective study; this report includes a subset of 21 participants who complete the qualitative and quantitative assessments between May 2023 and January 2024. Methods: Semi structured interviews using open‐ended questions were conducted and analysed using a thematic analysis approach. Participants were interviewed after completing an 8‐week hybrid home‐based rehabilitation programme, including four face‐to‐face and four remote sessions. Quantitative assessments—covering disease impact, anxiety and depressive symptoms, and exercise tolerance—were conducted at the beginning and end of the intervention in the same participants who took part in the interviews, and a 10‐item satisfaction questionnaire was also completed after the programme. Data Sources: May 2023 to January 2024. Reporting Method: GRAMMS checklist was followed. Results: 21 people with chronic obstructive pulmonary disease (11 females; mean age 62 ± 7 years; mean FEV 1 30% ± 10% of predicted) were interviewed. Five major themes were identified: (i) accessibility and adaptation to individual needs; (ii) confidence in the transdisciplinary care manager model, confirmed by high satisfaction score (95/100); (iii) integration of informal carers; (iv) perceived benefits supporting maintenance of health behaviour, consistent with the statistically and clinically significant improvements observed across all quantitative outcomes; and (v) hybrid programme challenges (technical issues and preference for face‐to‐face visits). Conclusion: The hybrid programme resulted in significant improvements in physical and psychological outcomes, and participants reported high levels of satisfaction. Qualitative findings highlighted the value of home‐based delivery, supervision by a single care manager, informal carer involvement and emotional support in shaping feasibility and satisfaction. However, challenges related to remote sessions indicate that telerehabilitation may not be suitable for all patients and should not be used as a standalone PR option. Relevance for Clinical Practice: Given the strong preference of participants for face‐to‐face visits over remote visits, telerehabilitation should always include a minimum of individual or group face‐to‐face supervised sessions. The balance between supervision modalities should be personalised according to participants' needs and progress.
- 4 February 2026
- Published by Wiley in Journal of Clinical Nursing
- Vol. 35 (6) , 2658-2671
Open AccessIs a Hybrid Pulmonary Rehabilitation Programme Feasible and Effective in Individuals With COPD After an Exacerbation‐Related Hospitalisation: A Mixed Methods Study
Aim: To combine qualitative and quantitative data to evaluate the feasibility, participant satisfaction and effectiveness of a hybrid pulmonary rehabilitation programme following hospital discharge for an exacerbation of chronic obstructive pulmonary disease (COPD). Design: Convergent parallel mixed method study nested in a larger ongoing prospective study; this report includes a subset of 21 participants who complete the qualitative and quantitative assessments between May 2023 and January 2024. Methods: Semi structured interviews using open‐ended questions were conducted and analysed using a thematic analysis approach. Participants were interviewed after completing an 8‐week hybrid home‐based rehabilitation programme, including four face‐to‐face and four remote sessions. Quantitative assessments—covering disease impact, anxiety and depressive symptoms, and exercise tolerance—were conducted at the beginning and end of the intervention in the same participants who took part in the interviews, and a 10‐item satisfaction questionnaire was also completed after the programme. Data Sources: May 2023 to January 2024. Reporting Method: GRAMMS checklist was followed. Results: 21 people with chronic obstructive pulmonary disease (11 females; mean age 62 ± 7 years; mean FEV 1 30% ± 10% of predicted) were interviewed. Five major themes were identified: (i) accessibility and adaptation to individual needs; (ii) confidence in the transdisciplinary care manager model, confirmed by high satisfaction score (95/100); (iii) integration of informal carers; (iv) perceived benefits supporting maintenance of health behaviour, consistent with the statistically and clinically significant improvements observed across all quantitative outcomes; and (v) hybrid programme challenges (technical issues and preference for face‐to‐face visits). Conclusion: The hybrid programme resulted in significant improvements in physical and psychological outcomes, and participants reported high levels of satisfaction. Qualitative findings highlighted the value of home‐based delivery, supervision by a single care manager, informal carer involvement and emotional support in shaping feasibility and satisfaction. However, challenges related to remote sessions indicate that telerehabilitation may not be suitable for all patients and should not be used as a standalone PR option. Relevance for Clinical Practice: Given the strong preference of participants for face‐to‐face visits over remote visits, telerehabilitation should always include a minimum of individual or group face‐to‐face supervised sessions. The balance between supervision modalities should be personalised according to participants' needs and progress.
- Open Access
- 16 January 2026
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 23
Does care managers’ initial professional background affect the outcomes of pulmonary rehabilitation? A retrospective cohort study of 2450 individuals with chronic respiratory diseases
Objective: This retrospective study in individuals with chronic respiratory diseases (CRDs) compared changes in quality of life, anxiety and depressive symptoms, and exercise capacity after a home pulmonary rehabilitation (PR) programme, based on the care manager’s professional background. Methods: PR team was composed of nurses (Gr1, n = 989 patients), physiotherapists (Gr2, n = 466), one dietician and one sociomedical beautician (Gr3, n = 794) and one respiratory physician (Gr4, n = 201) who supervised one home session per week during 8 weeks. Quality of life, anxiety and depressive symptoms, dyspnea and exercise capacity were assessed at the beginning and end of PR, and at 12 months after the end of PR. Results: 2450 participants were included (females: 41.6%, age: 64.1 ± 13.0 years, FEV 1 : 50.7 ± 25.2% of predicted, people with COPD: 51%, with ILD: 23%, with asthma: 10%). Gr 1, Gr 3 and Gr 4 improved all the assessments at short- and long-term (p < 0.01). Improvement in the Visual Simplified Respiratory Questionnaire in Gr2 was not maintained at long-term. According to the linear mixed models, changes over time were not statistically different between groups. Conclusion: A personalised PR programme delivered by one care manager, led to similar short-term benefits regardless of the care manager’s initial professional background.
- 16 January 2026
- Published by SAGE Publications in Chronic Respiratory Disease
- Vol. 23
Open AccessDoes care managers’ initial professional background affect the outcomes of pulmonary rehabilitation? A retrospective cohort study of 2450 individuals with chronic respiratory diseases
Objective: This retrospective study in individuals with chronic respiratory diseases (CRDs) compared changes in quality of life, anxiety and depressive symptoms, and exercise capacity after a home pulmonary rehabilitation (PR) programme, based on the care manager’s professional background. Methods: PR team was composed of nurses (Gr1, n = 989 patients), physiotherapists (Gr2, n = 466), one dietician and one sociomedical beautician (Gr3, n = 794) and one respiratory physician (Gr4, n = 201) who supervised one home session per week during 8 weeks. Quality of life, anxiety and depressive symptoms, dyspnea and exercise capacity were assessed at the beginning and end of PR, and at 12 months after the end of PR. Results: 2450 participants were included (females: 41.6%, age: 64.1 ± 13.0 years, FEV 1 : 50.7 ± 25.2% of predicted, people with COPD: 51%, with ILD: 23%, with asthma: 10%). Gr 1, Gr 3 and Gr 4 improved all the assessments at short- and long-term (p < 0.01). Improvement in the Visual Simplified Respiratory Questionnaire in Gr2 was not maintained at long-term. According to the linear mixed models, changes over time were not statistically different between groups. Conclusion: A personalised PR programme delivered by one care manager, led to similar short-term benefits regardless of the care manager’s initial professional background.
- 17 January 2025
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 61 (5) , 308-310
Home Versus Outpatient Pulmonary Rehabilitation in People With Chronic Obstructive Pulmonary Disease: An Unselected and Propensity-Matched Real-Life Study
- 17 January 2025
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 61 (5) , 308-310
Home Versus Outpatient Pulmonary Rehabilitation in People With Chronic Obstructive Pulmonary Disease: An Unselected and Propensity-Matched Real-Life Study
- Open Access
Is longer really better? Results of a retrospective real-life cohort study evaluating the benefit of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation programme in people with COPD
Objectives To evaluate the short-term and long-term benefits of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation (PR) programme in people with chronic obstructive pulmonary disease (COPD). Primary hypothesis was that 8 home-based supervised sessions will be equivalent to 16 home-based supervised sessions at both short- and long-term after PR. Design Retrospective cohort study conducted on prospectively collected real-life data, from January 2010 to December 2021. Setting FormAction Santé, Pérenchies France. Participants Eligible individuals were aged >18 years with a diagnosis of COPD and referred to the home-based PR programme by their respiratory physician. Participants were retrospectively divided into two groups (Gr 1, 8 PR sessions, n=759, and Gr 2, 8 PR sessions+8 educational sessions, n=262). Intervention All participants received an 8-week personalised home PR programme. A subgroup of participants received one additional supervised home session per week, including education and motivational support for daily physical activities and walking. Outcomes Health-related quality of life, dyspnoea, anxiety and depressive symptoms, fatigue and exercise tolerance were assessed at baseline (M0), at the end of PR (M2), and 14 months (M14) after M0. Results Baseline characteristics and assessments were similar between groups with an exception for long-term oxygen therapy (Gr1: 69.8% vs Gr2 53.0%, pConclusion People with COPD benefited, at short and long terms, from both 8 or 16 supervised home-based PR sessions. Once-weekly home-based supervised sessions during 8 weeks, combined with unsupervised physical training sessions and self-management plan for the other health behaviours, might be the best compromise between patients, health professionals and policy makers.
Open AccessIs longer really better? Results of a retrospective real-life cohort study evaluating the benefit of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation programme in people with COPD
Objectives To evaluate the short-term and long-term benefits of adding a weekly educational session to a traditional 8-week home-based pulmonary rehabilitation (PR) programme in people with chronic obstructive pulmonary disease (COPD). Primary hypothesis was that 8 home-based supervised sessions will be equivalent to 16 home-based supervised sessions at both short- and long-term after PR. Design Retrospective cohort study conducted on prospectively collected real-life data, from January 2010 to December 2021. Setting FormAction Santé, Pérenchies France. Participants Eligible individuals were aged >18 years with a diagnosis of COPD and referred to the home-based PR programme by their respiratory physician. Participants were retrospectively divided into two groups (Gr 1, 8 PR sessions, n=759, and Gr 2, 8 PR sessions+8 educational sessions, n=262). Intervention All participants received an 8-week personalised home PR programme. A subgroup of participants received one additional supervised home session per week, including education and motivational support for daily physical activities and walking. Outcomes Health-related quality of life, dyspnoea, anxiety and depressive symptoms, fatigue and exercise tolerance were assessed at baseline (M0), at the end of PR (M2), and 14 months (M14) after M0. Results Baseline characteristics and assessments were similar between groups with an exception for long-term oxygen therapy (Gr1: 69.8% vs Gr2 53.0%, pConclusion People with COPD benefited, at short and long terms, from both 8 or 16 supervised home-based PR sessions. Once-weekly home-based supervised sessions during 8 weeks, combined with unsupervised physical training sessions and self-management plan for the other health behaviours, might be the best compromise between patients, health professionals and policy makers.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA3181
Home-based vs outpatient hospital-based pulmonary rehabilitation in people with chronic obstructive pulmonary disease.
Background: Traditional outpatient-based pulmonary rehabilitation (PR) faces several barriers that have been partially addressed by home-based programme. The aim of this retrospective real-life study was to compare the effectiveness of a home-based vs outpatient-based PR programme in unselected patients with COPD. Methods: The home-based PR programme consisted of a weekly supervised 90-minute home session (+ 4 unsupervised sessions), during 8 weeks. The outpatient-based programme consisted of 4 supervised sessions a week, during 6 weeks (24 sessions, group of 8 patients). Both programmes included physical training, education and psychosocial and motivational support. Quality of life (VSRQ), exercise tolerance (6-minute Stepper Test) and anxiety and depressive symptoms (HAD) were assessed. Results: 1192 and 507 patients with COPD were included in home-based and outpatient-based PR, respectively. At baseline, the home-based group was younger (65vs.70 years), had more severe obstruction (FEV1: 38vs.52%), more impaired quality of life (31.2vs.38.7 points) and exercise tolerance (300vs.463 strokes), and a higher depression score (7.9vs.6.4 points), compared to the outpatient group (p<0.01). All the outcomes were improved by PR in both groups (p<0.001), with greater improvement in depressive symptoms (p<0.05) for the home-based group, and in exercise capacity (p<0.001) for the outpatient-based group. Conclusion: Although patients in the home-based group were initially more severe than the outpatient-based group, both groups improved all the outcomes after PR. This real-life study suggests that personalized home-based PR is effective and should be developed more widely.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA3181
Home-based vs outpatient hospital-based pulmonary rehabilitation in people with chronic obstructive pulmonary disease.
Background: Traditional outpatient-based pulmonary rehabilitation (PR) faces several barriers that have been partially addressed by home-based programme. The aim of this retrospective real-life study was to compare the effectiveness of a home-based vs outpatient-based PR programme in unselected patients with COPD. Methods: The home-based PR programme consisted of a weekly supervised 90-minute home session (+ 4 unsupervised sessions), during 8 weeks. The outpatient-based programme consisted of 4 supervised sessions a week, during 6 weeks (24 sessions, group of 8 patients). Both programmes included physical training, education and psychosocial and motivational support. Quality of life (VSRQ), exercise tolerance (6-minute Stepper Test) and anxiety and depressive symptoms (HAD) were assessed. Results: 1192 and 507 patients with COPD were included in home-based and outpatient-based PR, respectively. At baseline, the home-based group was younger (65vs.70 years), had more severe obstruction (FEV1: 38vs.52%), more impaired quality of life (31.2vs.38.7 points) and exercise tolerance (300vs.463 strokes), and a higher depression score (7.9vs.6.4 points), compared to the outpatient group (p<0.01). All the outcomes were improved by PR in both groups (p<0.001), with greater improvement in depressive symptoms (p<0.05) for the home-based group, and in exercise capacity (p<0.001) for the outpatient-based group. Conclusion: Although patients in the home-based group were initially more severe than the outpatient-based group, both groups improved all the outcomes after PR. This real-life study suggests that personalized home-based PR is effective and should be developed more widely.